[1]
2011. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? . Clinics. 66, 7 (Jan. 2011), 1171–1175. DOI:https://doi.org/10.1590/S1807-59322011000700008.